No of employees:
The Cabinet Committee on Economic Affairs approved the proposal of the Ministry of Health & Family Welfare for establishment of Integrated Vaccines Complex (IVC) at Chengalpattu, Kanchipuram district (Tamil Nadu) at an estimated cost of Rs. 594 crore (USD 120 million). The project is planned to be completed by 2015.
M/s HLL Lifecare Limited has formed a 100% subsidiary company, HLL Biotech Limited for implementing the project. HLL Biotech Limited corporate office is located at TICEL Biopark (Module 013, 014, 015) at TICEL Biopark, Taramani, Chennai, Tamilnadu.
IVC is a â€œProject of National Importanceâ€ which will ensure the uninterrupted supply of vaccines for the UIP at affordable prices. The state-of-the-art facility, the first of its kind in the public sector, will also have the future plan for any other vaccine for the immunization program for the country
The vaccine complex will be the nodal centre for research, manufacture and supply of vaccines at affordable prices for the Universal Immunization Program (UIP) of the Government of India. The vaccines to be manufactured in the IVC are Pentavalent combination (DPT plus Hep B plus Hib), BCG, Measles, Hepatitis B, Rabies, Hib and JEvaccine. The annual capacity of IVC is expected to be around 585 million doses. The vaccines produced in the complex will be utilized for immunization of infants and small children against various diseases through out the country.